Company · CIK 0001885522 · SIC 2836 — Biological Products, (No Diagnostic Substances) · Nasdaq
Neumora Therapeutics, Inc. · NMRA
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 20, 2026 SForm 4 → | Aug 21, 7:10 pm EDT | Daljit Singh AuroraSee Remarks | 176,060 | $1.53 | $269,967 | 0 | −100% | |
| Aug 20, 2026 MForm 4 → | Aug 21, 7:10 pm EDT | Daljit Singh AuroraSee Remarks | 176,060 | $0.72 | $126,763 | 21,055 | — | |
| Aug 17, 2026 SForm 4 → | Aug 19, 7:17 pm EDT | Daljit Singh AuroraSee Remarks | 277,773 | $1.55 | $431,674 | 0 | −100% | |
| Aug 17, 2026 MForm 4 → | Aug 19, 7:17 pm EDT | Daljit Singh AuroraSee Remarks | 243,753 | $0.72 | $175,502 | 30,918 | — |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 20, 2026 AMForm 4 → | Aug 21, 7:10 pm EDT | Daljit Singh AuroraSee Remarks | 376,060 | — | — | 94,798 | — | |
| Aug 20, 2026 AForm 4 → | Aug 21, 7:10 pm EDT | Paul L BernsSee Remarks, Director | 500,000 | — | — | 500,000 | — | |
| Aug 20, 2026 AForm 4 → | Aug 21, 7:08 pm EDT | Jason DuncanSee Remarks | 375,000 | — | — | 375,000 | — | |
| Aug 20, 2026 AForm 4 → | Aug 21, 7:08 pm EDT | Michael Lee MilliganSee Remarks | 175,000 | — | — | 175,000 | — | |
| Aug 20, 2026 AForm 4 → | Aug 21, 7:06 pm EDT | Joshua PintoPresident & CEO, Director | 500,000 | — | — | 500,000 | — | |
| Aug 17, 2026 MForm 4 → | Aug 19, 7:17 pm EDT | Daljit Singh AuroraSee Remarks | 243,753 | — | — | 45,026 | — |